GB939302636A
GB9302636D0
(en)
|
1993-02-10 |
1993-02-10 |
Compounds
|
PCT/GB1994/000237
WO1994018216A1
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
PL94310160A
PL175623B1
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
AT94905810T
ATE159950T1
(en)
|
1993-02-10 |
1994-02-08 |
N-ALKYL-2-SUBSTITUTED ATP ANALOGUES
|
DK94905810.1T
DK0683789T3
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted ATP analogs
|
CA002155673A
CA2155673C
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
ES94905810T
ES2108425T3
(en)
|
1993-02-10 |
1994-02-08 |
ATP ANALOGS REPLACED WITH N-ALKYL-2.
|
HU9502348A
HU221501B
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
SG1996005584A
SG47943A1
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
KR1019950703322A
KR100315612B1
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted adenosine triphosphate homologue
|
EP94905810A
EP0683789B1
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
NZ261159A
NZ261159A
(en)
|
1993-02-10 |
1994-02-08 |
Atp analogue and pharmaceutical compositions thereof
|
SK994-95A
SK281309B6
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted atp analogues
|
CN94191559A
CN1042430C
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted ATP analogues
|
ZA94854A
ZA94854B
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-1-substituted ATP analogues
|
JP06517805A
JP3083156B2
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted ATP analogs
|
CZ952032A
CZ286050B6
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted adenosinetriphosphate derivatives, process of their preparation and pharmaceutical compositions containing thereof
|
DE69406649T
DE69406649T2
(en)
|
1993-02-10 |
1994-02-08 |
N-ALKYL-2 SUBSTITUTED ATP ANALOGS
|
RU95118285/04A
RU2136693C1
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-substituted atp derivatives and method of preparation thereof
|
TW083101092A
TW326045B
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted ATP analogues the invention relates to a compound of formula (I) and its pharmaceutically acceptable salt which can be used for inhibition of platelet aggregation.
|
AU59770/94A
AU679721B2
(en)
|
1993-02-10 |
1994-02-08 |
N-alkyl-2-substituted ATP analogues
|
IL10860294A
IL108602A
(en)
|
1993-02-10 |
1994-02-09 |
Derivatives of N-alkyl-2-(substituted thio) adenylic acid monoanhydride with a substituted methylene phosphonic acid their preparation and pharmaceutical compositions containing them
|
UA95094059A
UA54366C2
(en)
|
1993-02-10 |
1994-08-02 |
N-alkyl-2-substituted analogues of adenosine triphosphate, methods for synthesis and pharmaceutical composition
|
HU9500084P
HU210812A9
(en)
|
1993-02-10 |
1995-02-21 |
N-alkyl-2-substituted atp analogues
|
US08/512,979
US5721219A
(en)
|
1993-02-10 |
1995-08-09 |
N-alkyl-2-substituted ATP analogues and administration to inhibit platelet aggregation
|
NO953126A
NO305209B1
(en)
|
1993-02-10 |
1995-08-09 |
N-alkyl-2-substituted ATP analogs, such compounds for the preparation of therapeutics, pharmaceutical preparations containing such compounds, and their use
|
FI953794A
FI110687B
(en)
|
1993-02-10 |
1995-08-10 |
Process for the preparation of N-alkyl-2-substituted ATP analogs
|
US08/918,670
US5955447A
(en)
|
1993-02-10 |
1997-08-28 |
N-alkyl-2-substituted ATP analogues for treatment of embolic disease conditions
|
GR980400166T
GR3025995T3
(en)
|
1993-02-10 |
1998-01-26 |
N-alkyl-2-substituted atp analogues.
|
HK98102001A
HK1002936A1
(en)
|
1993-02-10 |
1998-03-10 |
N-alkyl-2-substituted atp analogues
|